Sensus Healthcare, Inc. (SRTS) Stock
Healthcare · Medical Devices · Member of Other US Stocks
Sensus Healthcare, Inc. (SRTS) closed at USD 2.86 on 2026-10-14, a change of -12.5 % over the past year, with a market capitalization of USD 45.6M.
Sensus Healthcare, Inc. recent closing prices
| Date | Close (USD) |
|---|---|
| 2026-10-14 | 2.86 |
| 2026-10-13 | 2.89 |
| 2026-10-12 | 2.93 |
| 2026-10-09 | 2.95 |
| 2026-10-08 | 2.97 |
| 2026-10-07 | 2.94 |
| 2026-10-06 | 2.97 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
Sensus Healthcare, Inc. key figures
- Previous close
- USD 2.86 (2026-10-14)
- 1-year change
- -12.5 %
- Market cap
- USD 45.6M
- Enterprise value
- USD 30.76M
- P/E ratio (trailing)
- -3.08
- P/E ratio (forward)
- -15.98
- EPS (trailing)
- -0.90
- EPS (forward)
- -0.17
- PEG ratio
- n/a
- Price to book
- 1.24
- Revenue growth
- -68.7 %
- Earnings growth
- n/a
- Dividend per share (trailing)
- 0.00
- Short ratio
- 6.90
- Employees
- 60
- Analyst consensus (third-party)
- none
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About Sensus Healthcare, Inc.
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 +; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos, as well as provide operational healthcare services for dermatology clinics. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. The company was incorporated in 2010 and is based in Boca Raton, Florida.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for Sensus Healthcare, Inc. and compare it with other stocks.
Analyze SRTSAll Other US Stocks stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell Sensus Healthcare, Inc. shares.